Drugs / GLA5PR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03963362 | Sep 2019 → Dec 2020 | neuropathy, painful | GL Pharm Tech Corporation | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GLA5PR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03963362 ↗ |